share_log

Ginkgo Bioworks | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.20%)

SEC announcement ·  Feb 14 11:51
Summary by Futu AI
The Vanguard Group has filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of Ginkgo Bioworks Holdings, Inc. Class A common stock. As of December 29, 2023, The Vanguard Group owns an aggregate amount of 132,779,676 shares, representing 8.20% of the class. This filing, dated February 13, 2024, shows that The Vanguard Group has shared voting power over 461,957 shares and sole dispositive power over 130,958,928 shares, with an additional shared dispositive power over 1,820,748 shares. The filing asserts that the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing the control of the issuer.
The Vanguard Group has filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of Ginkgo Bioworks Holdings, Inc. Class A common stock. As of December 29, 2023, The Vanguard Group owns an aggregate amount of 132,779,676 shares, representing 8.20% of the class. This filing, dated February 13, 2024, shows that The Vanguard Group has shared voting power over 461,957 shares and sole dispositive power over 130,958,928 shares, with an additional shared dispositive power over 1,820,748 shares. The filing asserts that the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing the control of the issuer.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.